Home/Umoja Biopharma/Andrew Scharenberg, M.D.
AS

Andrew Scharenberg, M.D.

Co-founder & Chief Executive Officer

Umoja Biopharma

Umoja Biopharma Pipeline

DrugIndicationPhase
UB-VV111Relapsed/Refractory B-Cell MalignanciesPhase 1